Share
Market Research Report

TARGETED RADIOPHARMACEUTICAL THERAPY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Segmentation
  • By Radionuclide TypeAlpha Emitters · Beta Emitters
  • By Therapeutic IsotopeLutetium-177 (Lu-177) · Actinium-225 (Ac-225) · Radium-223 (Ra-223) · Iodine-131 (I-131) · Others
  • By ApplicationProstate Cancer · Neuroendocrine Tumors · Thyroid Cancer · Bone Metastases · Others
  • By End UserHospitals · Specialty Cancer Centers · Academic and Research Institutes · Others
  • By GeographyNorth America · Europe · Asia Pacific · Latin America · Middle East · and Africa
  • Published In17 Nov 2026
  • Report CodeCMI10423
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026 - 2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Global Targeted Radiopharmaceutical Therapy Market, By Radionuclide Type
      • Global Targeted Radiopharmaceutical Therapy Market, By Therapeutic Isotope
      • Global Targeted Radiopharmaceutical Therapy Market, By Application
      • Global Targeted Radiopharmaceutical Therapy Market, By End User
      • Global Targeted Radiopharmaceutical Therapy Market, By Region
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Impact Analysis
    • Key Highlights
    • Regulatory Scenario
    • Radionuclide Type Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Market Opportunities
    • Industry Trends
  4. Global Targeted Radiopharmaceutical Therapy Market, By Radionuclide Type, 2021-2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Alpha Emitters
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Beta Emitters
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  5. Global Targeted Radiopharmaceutical Therapy Market, By Therapeutic Isotope, 2021-2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Lutetium-177 (Lu-177)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Actinium-225 (Ac-225)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Radium-223 (Ra-223)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Iodine-131 (I-131)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  6. Global Targeted Radiopharmaceutical Therapy Market, By Application, 2021-2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Prostate Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Neuroendocrine Tumors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Thyroid Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Bone Metastases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  7. Global Targeted Radiopharmaceutical Therapy Market, By End User, 2021-2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Specialty Cancer Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Academic and Research Institutes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  8. Global Targeted Radiopharmaceutical Therapy Market, By Region, 2021 - 2033, Value (USD Bn)

    • Introduction
      • Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
      • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, By Radionuclide Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Therapeutic Isotope, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, By Radionuclide Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Therapeutic Isotope, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, By Radionuclide Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Therapeutic Isotope, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, By Radionuclide Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Therapeutic Isotope, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, By Radionuclide Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Therapeutic Isotope, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, By Radionuclide Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Therapeutic Isotope, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
        • South Africa
        • North Africa
        • Central Africa
  9. Competitive Landscape

    • Aptamer Group plc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Bayer AG
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Eli Lilly and Company
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Bristol Myers Squibb Company
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • AstraZeneca PLC
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Telix Pharmaceuticals Limited
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • ITM Isotope Technologies Munich SE
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Curium Pharma
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Actinium
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Perspective Therapeutics, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
  10. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  11. References and Research Methodology

    • References
    • Research Methodology
    • About us

*Browse 32 market data tables and 28 figures on Targeted Radiopharmaceutical Therapy Market' - Global forecast to 2033